Literature DB >> 11758637

Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community?

J Okuno1, H Yanagi, S Tomura.   

Abstract

OBJECTIVE: The association between cognitive impairment and compliance with prescribed medications was investigated among functionally independent Japanese elderly in the community.
SUBJECTS: The subjects of this study were 220 elderly persons aged 60 years and over, who lived in the community. All participants were taking a regimen of one or more prescribed drugs. We included elderly with mild to moderate cognitive impairment. Medication use was observed by pharmacist-conducted interviews during home visits. Compliance was estimated by the pill count method. The Mini-Mental State Examination (MMSE) was used to estimate cognitive function.
RESULTS: The mean age (SD) of the subjects was 75.7 (6.9) years. Of the subjects, 58 (26.4%) were cognitively impaired (MMSE < or = 23), and 76 (34.6%) exhibited poor compliance (rate of compliance< 80%). Poor compliance was associated with the subjects who had a lower education level, had lower MMSE scores, had concern about taking drugs, who intentionally self-selected (intentional noncompliance) prescribed drugs, had a poor relationship with a physician, who did not have one dose package, and those who did not use a medical calendar. In multiple logistic regression analyses, intentional noncompliance (OR 19.65, 95%, CI 9.22-41.92; OR, odds ratio; CI, confidence interval), cognitive impairment (MMSE < or = 23; OR 2.94, 95%, CI 1.32-6.58), and a poor relationship with a physician (OR 6.24. 95%, CI 1.55-25.20) were independent predictors of poor compliance for elderly in the community.
CONCLUSION: We found that cognitive impairment was one of the predictors for poor compliance among the elderly who are functionally independent in the community. Intentional noncompliance was the strongest predictor for poor compliance, which was influenced by the relationship between patient and physician. Physicians should establish good communication with their elderly patients and provide some support to compensate for cognitive impairment.

Entities:  

Mesh:

Year:  2001        PMID: 11758637     DOI: 10.1007/s002280100347

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  41 in total

1.  Neuropsychological correlates of suboptimal adherence to metformin.

Authors:  Marc I Rosen; John E Beauvais; Michael O Rigsby; Jamelah T Salahi; Caitlin E Ryan; Joyce A Cramer
Journal:  J Behav Med       Date:  2003-08

2.  Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.

Authors:  John M Kane; Taishiro Kishimoto; Christoph U Correll
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

3.  Using the transtheoretical model's stages of change to predict medication adherence in patients with type 2 diabetes mellitus in a primary health care setting.

Authors:  Yara Arafat; Mohamed Izham Mohamed Ibrahim; Ahmed Awaisu; Stephen Colagiuri; Yaw Owusu; Donald E Morisky; Mudather AlHafiz; Ahmed Yousif
Journal:  Daru       Date:  2019-02-07       Impact factor: 3.117

4.  Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma.

Authors:  Hira Mian; Mark Fiala; Tanya M Wildes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-10-09

Review 5.  Improving medication adherence among community-dwelling seniors with cognitive impairment: a systematic review of interventions.

Authors:  Edeltraut Kröger; Ovidiu Tatar; Isabelle Vedel; Anik M C Giguère; Philippe Voyer; Laurence Guillaumie; Jean-Pierre Grégoire; Line Guénette
Journal:  Int J Clin Pharm       Date:  2017-05-29

6.  Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.

Authors:  Grant W Cannon; Ted R Mikuls; Candace L Hayden; Jian Ying; Jeffrey R Curtis; Andreas M Reimold; Liron Caplan; Gail S Kerr; J Steuart Richards; Dannette S Johnson; Brian C Sauer
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-12       Impact factor: 4.794

7.  Incident Heart Failure and Cognitive Decline: The Atherosclerosis Risk in Communities Study.

Authors:  Jan Bressler; David S Knopman; A Richey Sharrett; Rebecca F Gottesman; Alan Penman; Patricia P Chang; Wayne D Rosamond; Eric Boerwinkle; Thomas H Mosley
Journal:  J Card Fail       Date:  2016-11-15       Impact factor: 5.712

8.  Associations Among Depressive Symptoms, Wellness, Patient Involvement, Provider Cultural Competency, and Treatment Nonadherence: A Pilot Study Among Community Patients Seen at a University Medical Center.

Authors:  Lisa M Hooper; Lauren E Huffman; John C Higginbotham; George C T Mugoya; Annie K Smith; Tia N Dumas
Journal:  Community Ment Health J       Date:  2017-04-05

9.  Cognitive impairment and nocturnal blood pressure fall in treated elderly hypertensives.

Authors:  Junko Okuno; Hisako Yanagi
Journal:  Environ Health Prev Med       Date:  2003-09       Impact factor: 3.674

10.  Incidence and documentation of cognitive impairment among older adults with severe mental illness in a community mental health setting.

Authors:  R Scott Mackin; Patricia A Areán
Journal:  Am J Geriatr Psychiatry       Date:  2009-01       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.